Abstract
Central nervous system (CNS) tumors are the most prevalent solid neoplasms in pediatrics. Medullo- blastoma is the most frequent embryonal tumor of the CNS and corresponds to approximately 20% of cases. Objective: to describe the experience in the diagnosis, treatment, and results of patients with medulloblastoma in a reference center in Colombia. Methods: 38 patients were included from January 2011 to December 2018. Results: those under 3 years of age received treatment based on the CCG9921 protocol and those over 3 years of age treatment based on the ACNS0332 protocol. Overall survival at 5 years was 50.6%. The overall survival of the entire group is low compared to countries with higher incomes due to multiple factors such as access barriers. Conclusion: It is im- portant to establish national guidelines that allow earlier diagnosis and risk-adjusted treatment. Also, it is important to collect information from multiple centers in order to evaluate the results and propose improvements in health policies.

This publication has 25 references indexed in Scilit: